Rebecca Araujo

DocwireNews

Monotherapy with daratumumab, an anti-CD38 human monoclonal IgG1&kappa; antibody, showed clinical efficacy in treating patients with severe immunoglobulin light chain (AL) amyloidosis and biopsy-proven renal involvement, according to findings from a <a href="https://www.mdpi.com/2077-0383/9/10/3232">small study</a> published in the Journal of Clinical Medicine.AL amyloidosis, when the immune system produces abnormal antibodies called light chains, is associated with short survival. The therapy goal for this disorder is suppression pathologic light chain precursor production in order to improve organ impairment. Current treatments, such as daratumumab, have been adopted from multiple myeloma and are based on chemotherapy that targets the underlying plasma cell clone.This trial aimed to assess clinical activity and toxicity of daratumumab as a single agent in the treatment of AL amyloidosis. Five patients with severe AL amyloidosis and biopsy-proven renal involvement received daratumumab 16 mg/kg intravenously weekly for eight consecutive weeks, then every two weeks for eight cycles, and finally once monthly for up to 52 weeks. Two patients were either refractory or intolerant to conventional bortezomib-based therapy, two were treated for relapsing disease, and one was receiving daratumumab as frontline therapy.Daratumumab demonstrated clinical efficacy, with a reduction in M-proteins in four out of five patients, serum free light chains (sFLC) ratio normalization in three out of four, and amelioration in the remaining patient. The four patients with preserved renal function at baseline also showed serum creatinine stabilization and a decrease in proteinuria.&ldquo;Our data, based on real-life experience and strong parameters of definition of the renal involvement, showed this regimen to be a beneficial therapeutic option capable not only of inducing rapid hematologic response but also achieving a substantial rate of renal improvement in pretreated and na&iuml;ve patients,&rdquo; the researchers concluded.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Daratumumab Monotherapy Shows Promise for Severe AL Amyloidosis with Renal Involvement

Oncology

Monotherapy with daratumumab, an anti-CD38 human monoclonal IgG1κ antibody, showed clinical efficacy in treating patients with severe immunoglobulin light chain (AL) ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe